Filing Details
- Accession Number:
- 0001104659-14-066646
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-09-16 18:15:27
- Reporting Period:
- 2014-09-15
- Filing Date:
- 2014-09-16
- Accepted Time:
- 2014-09-16 18:15:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1070081 | Ptc Therapeutics Inc. | PTCT | Pharmaceutical Preparations (2834) | 043416587 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1550424 | Mark Rothera | C/O Ptc Therapeutics, Inc., 100 Corporate Court South Plainfield NJ 07080 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-09-15 | 3,000 | $36.68 | 22,000 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-09-15 | 3,160 | $35.72 | 18,840 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-09-15 | 1,840 | $36.41 | 17,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sale transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on August 21, 2013, as amended on March 17, 2014 and August 12, 2014.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $36.40 to $37.30 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $35.05 to $36.02 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $36.21 to $36.53 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
